|
⚲
|
| Keyboard |
| Alphagen Capital Limited
✚
|
|
|---|---|
| CRD # | 137841 |
| SEC # | 801-65237 |
| CIK # | 0001457236 |
| AUM | |
| Employees | 49 (73% Investors, 4% Brokers) |
| Fees | |
| Minimum | |
| Phone | 442078181818 |
| Address | 201 Bishopsgate London, United Kingdom |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/29/2019) [Brochure] |
|---|
Item 5: Fees and Compensation ACL typically receives an investment management fee from the Funds and Separate Accounts for its investment advisory services. ACL’s fee schedule for the Funds and Separate Accounts is between 0% (which might apply as an incentive for seed capital) and 2.0% of net asset value of the relevant Fund or Separate Account. Such fee is calculated each month before deduction of that month's fee and before deduction for any accrued performance fees as of each valuation day. Generally, the investment management fee is payable monthly in arrears and is disclosed in each Fund offering document. Fees for both the Funds and Separate Accounts may be negotiated. For certain Funds and Separate Accounts, ACL may also receive a fee based on the performance achieved by a Fund or Separate Account over a specific time period. See Item 6 – Performance-Based Fees and Side-By-Side Management for more information about performance-based fees. In addition to ACL’s investment management fee, clients may incur operating and transaction fees, costs and expenses associated with maintaining their accounts imposed by custodians, brokers, futures commission merchants, prime brokers and other third-parties. Examples of these charges include but are not limited to custodial fees, margin, deferred sales charges, “mark-ups” and “mark-downs” on trades, odd-lot differentials, transfer taxes, handling charges, exchange fees (including foreign currency exchange fees), interest to cover short positions, wire transfer fees, electronic fund fees, conversion fees for American Depository Receipts (“ADRs”) and other fees and taxes on brokerage accounts and securities transactions. ACL does not receive any portion of these commissions, fees or costs. See, however, Item 12 – Brokerage Practices for more information about commission credits and conversion fees for ADRs. Investors in the Funds pay expenses in addition to investment management fees and performance fees, if applicable. These expenses generally include administration, organizational, research and investment expenses, such as brokerage commissions, legal, line of credit, director, accounting, audit and other professional fees and expenses. For additional detail on these fees and expenses, please refer to a Fund’s offering documents. To the extent ACL engages a sub-adviser, ACL will pay the sub-adviser a portion of the management fee that clients pay to ACL. ACL’s clients do not pay any fees, commissions or expenses directly to sub- advisers. Further, to the extent ACL acts as a sub-adviser, ACL will receive a portion of the management fee, and performance fee if applicable, the end clients pay to the adviser. These clients do not pay any fees, commissions or expenses directly to ACL. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/29/2019) [Brochure] |
|---|
Item 7: Types of Clients
ACL provides or may provide discretionary investment advisory and sub-advisory services to U.S. and non-
U.S. institutional clients, including:
pooled investment vehicles, including private funds,
other investment advisers
pension and profit sharing plans,
sovereign-wealth funds and foreign official institutions,
charitable organizations, and
corporations or business entities other than those listed previous.
ACL may make its non-U.S. funds available in individuals and high-net worth individuals, including trusts and
estates. ACL generally makes its Private Funds only available to “qualified purchasers”. The minimum initial
investment in the Private Funds with respect to U.S. shares, or foreign currency equivalent for other shares,
is generally $100,000 and the minimum amount of additional investments is generally $100,000. Per the
relevant offering documents, in certain Private Funds, the minimum initial investment is generally $1,000,000
or $5,000,000.
ACL may, in conjunction with any Private Fund governing body, waive account minimums based on certain
criteria, including product type, investment strategy, client type, client domicile, services provided, the client’s
historical relationship with the firm, number of related investment accounts, account composition or size,
anticipated future earning capacity, current and anticipated future assets under management, marketplace
considerations, early adoption of an investment strategy or investment in a particular vehicle, client’s
operational or investment limitations or restrictions, level of client servicing required and other factors as the
Directors may determine generally or in any particular case, where permitted under law. ACL, in conjunction
with any Private Fund governing body, may also waive account minimums for employees, including portfolio
managers, affiliates or relatives of such persons.
As shares in Private Funds are sold only to a limited number “qualified purchasers”, are not organized or
created under U.S. law, and/or are not advertised or offered for purchase in the U.S., the Private Funds are
not registered as “investment companies” under the Investment Company Act. The absence of registration
places limits on the number and/or types of persons who may invest in the Private Funds. |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Microsoft Corp | 8.0 | ||
| Apple Inc | 5.0 | ||
| Alphabet Inc | 4.0 | ||
| Amazon Com Inc | 3.6 | ||
| Mastercard Inc | 3.6 | ||
| Adobe Systems Inc | 2.7 | ||
| Merck & Co Inc | 2.6 | ||
| Facebook Inc | 2.5 | ||
| Salesforce Com Inc | 2.1 | ||
| Texas Instruments Inc | 1.8 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | The Alphagen Castor Fund Limited | 2017-07-28 | 197.0 M | |
| HF | The Alphagen Volantis Catalyst Fund II Limted | 2016-05-31 | 29.5 M | |
| HF | The Alphagen Altair Master Fund Limited | 2016-03-30 | 49.0 M | |
| HF | The Alphagen Altair Offshore Fund Limited | 2016-03-30 | 33.3 M | |
| HF | The Alphagen Elnath Fund Limited | 2016-03-30 | 21.5 M | |
| HF | The Alphagen Elnath Master Fund Limited | 2016-03-30 | 21.5 M | |
| HF | The Alphagen Japan Select Absolute Return Fund Limited | 2016-03-30 | 42.7 M | |
| HF | The Alphagen Japan Select Absolute Return Master Fund Limited | 2016-03-30 | 42.7 M | |
| HF | The Alphagen Liquidity Risk Premium Fund Limited | 2016-03-30 | 129.3 M | |
| HF | The Alphagen Long Short Agriculture Fund Limited | 2016-03-30 | 31.0 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 11 | 1.9 |
| (g) Pension and profit sharing plans | 0 | 0.1 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.1 |
| (n) Other | 0 | 0.0 |
| Total | 16 | 2.1 |
| By Discretionary | ||
| Discretionary | 16 | 2.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 16 | 2.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 1.7 | |
| United States Persons | 0.4 | |
| Total | 16 | 2.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Marc Towers | Director | 56 | 19 | |
| James O'Brien | Director | 57 | 10 | |
| Robert Bovet | Director | 78 | 8 | |
| Leslie Macdonald | Director | 11 | 6 | |
| Jim O'Brien | Executive Officer | 10 | 5 | |
| Hugh Ward | Director | 11 | 4 | |
| Neil Honebon | Director | 5 | 4 | |
| Andrew Steward | Director | 8 | 3 | |
| Arno Kitts | Director | 8 | 3 | |
| Henderson Global Investors North America Inc | Promoter | 4 | 3 | |
| Harry Romney | Director | 4 | 3 | |
| Henderson International GP LLC | Director | 3 | 3 | |
| Les Aitkenhead | Director | 5 | 2 | |
| Alphagen Capital Limited | Promoter | 2 | 2 | |
| JPMorgan Hedge Fund Services Ireland Limited | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001457236] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $4.4B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 213800PCL6YS5J6ES625 |